BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31937930)

  • 1. Mechanisms and pharmacokinetic/pharmacodynamic profiles underlying the low nephrotoxicity and ototoxicity of etimicin.
    Yao L; Zhang JW; Chen B; Cai MM; Feng D; Wang QZ; Wang XY; Sun JG; Zheng YW; Wang GJ; Zhou F
    Acta Pharmacol Sin; 2020 Jun; 41(6):866-878. PubMed ID: 31937930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new aminoglycoside etimicin shows low nephrotoxicity and ototoxicity in zebrafish embryos.
    Shao W; Zhong D; Jiang H; Han Y; Yin Y; Li R; Qian X; Chen D; Jing L
    J Appl Toxicol; 2021 Jul; 41(7):1063-1075. PubMed ID: 33094525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a sensitive LC-MS/MS method without derivatization/ion-pairing agents for etimicin quantification in rat plasma, internal ear and kidney.
    Yao L; Zhou F; Cai M; Peng Y; Sun J; Chen Q; Jin X; Wang G; Zhang J
    J Pharm Biomed Anal; 2017 Nov; 146():96-102. PubMed ID: 28881316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
    Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of etimicin in rat kidneys and alterations of its cytotoxicity to tubular epithelial cells.
    Li ZD; Zhang XL; Yi N; Zhang FC
    Hum Exp Toxicol; 2015 May; 34(5):479-86. PubMed ID: 25233899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity and ototoxicity in guinea pigs, and nephrotoxicity in rats of arbekacin.
    Kurebe M; Yokota M; Niizato T; Kai F; Yoshida T; Okamoto R; Mitsuhashi S
    Arzneimittelforschung; 1986 Oct; 36(10):1511-7. PubMed ID: 3814212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative ototoxicity of ribostamycin, dactimicin, dibekacin, kanamycin, amikacin, tobramycin, gentamicin, sisomicin and netilmicin in the inner ear of guinea pigs.
    Kitasato I; Yokota M; Inouye S; Igarashi M
    Chemotherapy; 1990; 36(2):155-68. PubMed ID: 2311443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ototoxicity of aminoglycoside antibiotics by rapid intravenous injection (author's transl)].
    Ohtani I; Ohtsuki K; Aikawa T; Takenaka M; Omata T; Ouchi J; Saito T
    Nihon Jibiinkoka Gakkai Kaiho; 1980 Nov; 83(11):1482-90. PubMed ID: 7277075
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antimicrobial activities of gentamicin against fresh clinical isolates].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K; Fukumoto T
    Jpn J Antibiot; 1990 Oct; 43(10):1674-84. PubMed ID: 2128340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial activities, nephrotoxicity, and ototoxicity of a new aminoglycoside, Win 42122-2.
    Came PE; O'Connor JR; Dobson RA; Wagner RB; Fabian RJ
    Antimicrob Agents Chemother; 1979 Dec; 16(6):813-22. PubMed ID: 533261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin.
    Matt T; Ng CL; Lang K; Sha SH; Akbergenov R; Shcherbakov D; Meyer M; Duscha S; Xie J; Dubbaka SR; Perez-Fernandez D; Vasella A; Ramakrishnan V; Schacht J; Böttger EC
    Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10984-9. PubMed ID: 22699498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in vitro activities of BB-K8 and three other aminoglycosides against 215 strains of Pseudomonas and Enterobacteriaceae with variable sensitivity to kanamycin and gentamicin.
    Yourassowsky E; Schoutens E; Vanderlinden MP
    Chemotherapy; 1975; 21(1):45-51. PubMed ID: 807457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nationwide survey on susceptibilities of clinical isolates from urinary tract to antimicrobial agents in Japan, 1991].
    Igari J
    Jpn J Antibiot; 1994 Mar; 47(3):255-67. PubMed ID: 8182896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside toxicity in neonates: something to worry about?
    Kent A; Turner MA; Sharland M; Heath PT
    Expert Rev Anti Infect Ther; 2014 Mar; 12(3):319-31. PubMed ID: 24455994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxic and ototoxic agents.
    Walker EM; Fazekas-May MA; Bowen WR
    Clin Lab Med; 1990 Jun; 10(2):323-54. PubMed ID: 2197052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial activities and PK/PD parameters of aminoglycosides against recent clinical isolates of gram-negative rods].
    Okubo T; Iyobe S
    Jpn J Antibiot; 2002 Oct; 55(5):514-23. PubMed ID: 12532635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal antibiotic concentrations of aminoglycosides and beta-lactam antibiotics for some gram-negative bacilli and gram-positive cocci.
    Lorian V; De Freitas CC
    J Infect Dis; 1979 May; 139(5):599-603. PubMed ID: 108345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.